Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VITAMINS Trial in Septic Shock
NCT03333278Phase 2Completed
- Sponsor
- Australian and New Zealand Intensive Care Research Centre
- Start
- May 2018
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of ascorbic acid, thiamine in septic shock, sponsored by Australian and New Zealand Intensive Care Research Centre. Started May 2018; status: completed.
02
Drugs
ascorbic acidthiamine
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT03333278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03333278.